Swing Therapeutics

Founded 

2019

 in 

San Francisco, California
Swing is a stealth mode prescription digital therapeutics company for rheumatologic diseases, fully incubated by JAZZ. Rheumatologic diseases – including osteoarthritis, psoriasis, fibromyalgia, and rheumatoid arthritis – are highly prevalent and debilitating, leading to $30B+ in annual drug spend, significant healthcare utilization, and lost productivity.

Stay Tuned

Subscribe to our newsletter and get updates on our portfolio companies.